Study | Target population | Country |
Primary care | ||
Blackburn et al35 | Patients with OA in primary care setting | UK |
Broadbent et al48 | Patients with OA in general practice | UK |
Doubova and Perez-Cuevas37 | Patients with KHOA aged ≥19 in family medicine | Mexico |
Jansen et al43 | Patients with KHOA in PT care | The Netherlands |
Marshall et al19 | Patients with OA in general practice | UK |
Peter et al44 | Patients with KHOA in PT care | The Netherlands |
Smith et al41 | Housebound elderly patients in home-based primary care | USA |
Steel et al**40 | People aged 65 and with OA in primary and secondary care | UK |
Vandenberghe et al47 | Patients with OA of aged ≥60 in general practice | Belgium |
Secondary care | ||
Saliba et al42 | Institutionalised vulnerable elderly with OA in nursing homes | USA |
Steel et al**40 | People aged 65 and with OA in primary and secondary care | UK |
Wierenga et al45 | Elderly hospitalised patients with OA from in-hospital pharmaceutical care | The Netherlands |
The entire spectrum of disciplines | ||
Asch et al36 | Patients of outpatient and inpatient care for acute and chronic conditions and preventive care (including OA) | USA |
Grypdonck et al49 | Patients with knee OA across the entire spectrum of disciplines | No country specified |
Hardcastle et al38 | People with OA aged ≥50 living in private households | UK |
MacLean31 | Vulnerable elderly with OA | USA |
MacLean et al33 | Patients with OA | USA |
MacLean et al32 | Vulnerable elderly with OA | USA |
Moore39 | Patients with OA | USA |
Østerås et al46 | Patients with OA | Norway |
Centralised intake care system | ||
Barber et al34 | Patients with RA and/or OA in centralised intake care system | Canada |
*Steel et al40 is listed twice in the table, as it focuses on ‘primary care’ and ‘secondary care’.
KHOA, knee and hip osteoarthritis; OA, osteoarthritis; PT, physiotherapy; RA, rheumatoid arthritis.